Biomarin Pharmaceutical SG&A Expense (Annual) Trends

Biomarin Pharmaceutical Inc (BMRN)

70.58 +0.34 (+0.48%) USD | NASDAQ | Sep 27, 16:00

70.59 +0.01 (+0.01%) After-Hours: 20:00

SG&A Expense (Annual) Chart

Historical SG&A Expense (Annual) Data

View and export this data back to 1998. Upgrade now.

Date	Value
December 31, 2023	937.30M
December 31, 2022	854.00M
December 31, 2021	759.40M
December 31, 2020	737.70M
December 31, 2019	680.90M
December 31, 2018	604.40M
December 31, 2017	554.34M
December 31, 2016	476.59M
December 31, 2015	402.27M
December 31, 2014	302.16M
December 31, 2013	235.36M
December 31, 2012	198.17M
December 31, 2011	175.42M

Date	Value
December 31, 2010	151.72M
December 31, 2009	124.29M
December 31, 2008	106.57M
December 31, 2007	77.54M
December 31, 2006	49.03M
December 31, 2005	41.56M
December 31, 2004	37.61M
December 31, 2003	14.40M
December 31, 2002	16.87M
December 31, 2001	6.391M
December 31, 2000	6.507M
December 31, 1999	4.757M
December 31, 1998	3.50M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Annual) Range, Past 5 Years

680.90M

Minimum

2019

937.30M

Maximum

2023

793.86M

Average

759.40M

Median

2021

SG&A Expense (Annual) Benchmarks